Umbilical cord-derived allogeneic mesenchymal stem cell therapy (Vitro Biopharma)

N/A

Report date: 2025/08/12 20:00:05

Base Information

Drug NameUmbilical cord-derived allogeneic mesenchymal stem cell therapy (Vitro Biopharma)
Drug Alias NameAlloRx stem cellsAlloRx
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsAutistic DisorderFrailtyDiabetes Mellitus +[38] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySloveniaAntigua and BarbudaArgentina +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVitro Diagnostics Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Foundation for Orthopaedics and Regenerative Medicine
Inactive CompaniesN/A
Active IndicationsAutistic DisorderFrailtySkin Ulcer +[30] 
Inactive IndicationsDiabetes MellitusAngina PectorisHeart Failure +[8] 

Other Information

ATC CodeN/A
Related LinksN/A